Idogen, a developer of tolerogenic cell therapies to prevent the immune system from attacking biological agents, transplanted organs or the body’s own cells or tissue, is looking into the possibility…
Idogen, a developer of tolerogenic cell therapies to prevent the immune system from attacking biological agents, transplanted organs or the body’s own cells or tissue, is looking into the possibility…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference